南京医药
(600713)
| 流通市值：49.62亿 | | | 总市值：62.10亿 |
| 流通股本：10.47亿 | | | 总股本：13.10亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,371,578,790.6 | 1,182,314,632.78 | 2,007,310,466.33 | 1,387,527,241.52 |
| 应收票据及应收账款 | 14,097,600,883.06 | 19,526,657,083.53 | 18,734,570,884.27 | 18,397,976,686.13 |
| 其中：应收票据 | 2,356,594,575.57 | 2,681,038,577.59 | 2,910,974,319.97 | 2,233,408,726.06 |
| 应收账款 | 11,741,006,307.49 | 16,845,618,505.94 | 15,823,596,564.3 | 16,164,567,960.07 |
| 应收款项融资 | 2,110,966,319.68 | 2,886,464,584.09 | 2,618,032,003.02 | 2,713,945,122.57 |
| 预付款项 | 893,908,095.68 | 733,454,452.06 | 855,618,204.86 | 942,547,090.3 |
| 其他应收款合计 | 587,886,068.28 | 664,659,327.94 | 623,240,000.39 | 609,744,789.99 |
| 存货 | 5,798,006,053.29 | 5,696,643,402.54 | 5,984,981,802.58 | 6,186,953,579.93 |
| 其他流动资产 | 152,950,364.14 | 121,819,796.14 | 165,433,130.5 | 211,359,569.21 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 26,012,896,574.73 | 30,812,013,279.08 | 30,989,186,491.95 | 30,450,054,079.65 |
| 非流动资产: | | | | |
| 长期股权投资 | 42,381,153.46 | 42,573,272.98 | 16,214,991.67 | 11,617,310.22 |
| 其他权益工具投资 | 195,260,945.74 | 198,328,894.19 | 199,980,058.74 | 213,897,017.09 |
| 投资性房地产 | 91,337,487.14 | 86,968,358.37 | 88,719,390.13 | 95,808,064.94 |
| 固定资产 | 1,137,474,678.03 | 1,172,311,630.06 | 1,179,374,423.94 | 1,193,258,416.17 |
| 在建工程 | 130,077,011.85 | 80,067,708.04 | 78,983,019.27 | 75,520,382.52 |
| 使用权资产 | 239,256,640.61 | 245,839,367.27 | 252,219,767.35 | 247,571,304.76 |
| 无形资产 | 218,975,973.01 | 218,129,898.8 | 227,119,872.82 | 231,168,924.2 |
| 商誉 | 72,166,924.65 | 72,166,924.65 | 72,166,924.65 | 72,166,924.65 |
| 长期待摊费用 | 43,341,824.7 | 43,635,133.5 | 44,861,542.88 | 42,716,957.89 |
| 递延所得税资产 | 222,817,442.88 | 225,816,811.64 | 219,874,575.72 | 222,228,808.48 |
| 其他非流动资产 | 4,245,059.26 | 4,977,852.11 | 3,193,007.26 | 1,671,802.17 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,397,335,141.33 | 2,390,815,851.61 | 2,382,707,574.43 | 2,407,625,913.09 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 28,410,231,716.06 | 33,202,829,130.69 | 33,371,894,066.38 | 32,857,679,992.74 |
| 流动负债: | | | | |
| 短期借款 | 1,763,670,998.06 | 3,696,194,834.68 | 4,300,626,628.68 | 4,572,035,684.82 |
| 应付票据及应付账款 | 9,693,580,896.21 | 9,523,194,865.11 | 9,738,020,481.37 | 9,320,435,182.07 |
| 其中：应付票据 | 2,784,320,468 | 2,487,812,375.5 | 2,653,286,263.82 | 2,522,112,109.66 |
| 应付账款 | 6,909,260,428.21 | 7,035,382,489.61 | 7,084,734,217.55 | 6,798,323,072.41 |
| 合同负债 | 103,573,925.58 | 122,634,087.22 | 136,755,085.81 | 170,394,595.16 |
| 应付职工薪酬 | 245,763,871.47 | 163,143,569.24 | 150,396,630.6 | 165,042,702.88 |
| 应交税费 | 209,345,678.6 | 228,149,656.98 | 187,530,646.31 | 191,738,102.58 |
| 其他应付款合计 | 2,077,392,524.4 | 2,867,851,628.43 | 3,327,656,605.32 | 3,664,358,247.93 |
| 应付股利 | - | 73,613,895.97 | 50,595,936.66 | 38,012,670.02 |
| 一年内到期的非流动负债 | 2,299,368,553.28 | 2,285,686,058.68 | 1,129,062,852.76 | 1,397,585,062.59 |
| 其他流动负债 | 2,173,337,103.13 | 4,670,962,733.77 | 3,675,377,732.88 | 3,678,982,622.27 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 18,566,033,550.73 | 23,557,817,434.11 | 22,645,426,663.73 | 23,160,572,200.3 |
| 非流动负债: | | | | |
| 长期借款 | 1,100,985,400 | 1,100,895,700 | 2,301,962,500 | 2,300,158,300 |
| 应付债券 | 1,016,791,666.67 | 1,008,869,444.44 | 1,000,947,200 | - |
| 租赁负债 | 119,022,001.48 | 121,693,810.86 | 129,638,587.54 | 134,426,456.24 |
| 递延收益 | 297,061,298.3 | 290,927,884.41 | 295,002,963.88 | 299,889,065.34 |
| 递延所得税负债 | 55,411,458.17 | 56,111,001.94 | 56,991,350.02 | 59,032,623.4 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 2,589,271,824.62 | 2,578,497,841.65 | 3,784,542,601.44 | 2,793,506,444.98 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 21,155,305,375.35 | 26,136,315,275.76 | 26,429,969,265.17 | 25,954,078,645.28 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,310,231,012 | 1,310,231,012 | 1,310,315,012 | 1,310,315,012 |
| 资本公积 | 2,459,659,283.91 | 2,456,295,105.03 | 2,452,894,885.12 | 2,432,983,967.5 |
| 减:库存股 | 35,898,200 | 35,927,720 | 36,093,200 | 38,584,360 |
| 其他综合收益 | 89,723,786.58 | 87,343,164.65 | 90,883,649.76 | 99,288,289.89 |
| 盈余公积 | 278,488,716.62 | 237,372,336.12 | 237,372,336.12 | 237,372,336.12 |
| 未分配利润 | 2,332,989,634.94 | 2,236,575,751.91 | 2,104,922,248.46 | 2,128,860,481.17 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 6,435,194,234.05 | 6,291,889,649.71 | 6,160,294,931.46 | 6,170,235,726.68 |
| 少数股东权益 | 819,732,106.66 | 774,624,205.22 | 781,629,869.75 | 733,365,620.78 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,254,926,340.71 | 7,066,513,854.93 | 6,941,924,801.21 | 6,903,601,347.46 |
| 负债和股东权益合计 | 28,410,231,716.06 | 33,202,829,130.69 | 33,371,894,066.38 | 32,857,679,992.74 |
| 公告日期 | 2024-04-08 | 2023-10-31 | 2023-08-31 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | | | |